A review of WHO International Standards for botulinum antitoxins

被引:31
|
作者
Jones, R. G. A. [1 ]
Corbel, M. J. [1 ]
Sesardic, D. [1 ]
机构
[1] Natl Inst Biol Stand & Controls, Div Bacteriol, Potters Bar EN6 3QG, Herts, England
关键词
antitoxin; standard; assay; botulinum;
D O I
10.1016/j.biologicals.2005.11.009
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Clostridium botulinam produces the most potent known toxins, with seven distinct serotypes currently defined (A-G). These toxins can cause a life threatening systemic toxicity whether through natural causes such as food poisoning, infant botulism, wound botulism, or through use as bio-terror agents (e.g. inhalational botulism). It was realised early on that standard reference botulinum antitoxins were required to reduce the variation between assays and ensure a consistent potency of therapeutic antitoxins and vaccines, and to define the serotype. This led to the International Unit being defined by the World Health Organisation (WHO) in the 1960s with the establishment of the first International Standards (IS) for serotypes A-F Since then botulinum antitoxin ISs have been used world wide as the 'yard stick' to measure the neutralising potency of antitoxins. These primary WHO ISs are used to calibrate in house working reagents that are more extensively utilised. A definition of the International Unit for serotype G antitoxin has yet to be defined or accepted by the WHO and urgently needs addressing. However, before September 11th 2001 there was very little interest in botulinum antitoxin IS and as a result stocks of most of the original preparations are now completely exhausted or depleted and replacements long overdue. We have reviewed the extensive history and availability of the primary WHO ISs and interim materials. All type A and B antitoxin materials were recently assayed and their relative activities confirmed against the original IS preparations. The recent increase in demand for these materials has further exacerbated the shortage. We describe here the production and characterization of stable freeze dried potential candidate replacements along with a new prospective first IS for type G antitoxin. Available toxin A reference preparations are also briefly reviewed. (c) 2005 The International Association for Biologicals. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:223 / 226
页数:4
相关论文
共 50 条
  • [2] ANTITOXINS AND BOTULINUM TOXIN TREATMENT
    HAMBLETON, P
    COHEN, HE
    PALMER, BJ
    MELLING, J
    BRITISH MEDICAL JOURNAL, 1992, 304 (6832): : 959 - 960
  • [3] New equine antitoxins to botulinum neurotoxins serotypes A and B
    Li, D.
    Mattoo, P.
    Keller, J. E.
    BIOLOGICALS, 2012, 40 (04) : 240 - 246
  • [4] Review of international standards for dosemeters
    Behrens, R.
    Ambrosi, P.
    RADIATION PROTECTION DOSIMETRY, 2008, 128 (02) : 159 - 168
  • [5] WHO international cytokine standards and reference preparations
    Tovey, Michael G.
    Wadhwa, Meenu
    Thorpe, Robin
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (03) : 425 - 426
  • [6] INTERNATIONAL STANDARDS FOR DRINKING-WATER - WHO
    JACOBSON, AR
    AMERICAN JOURNAL OF PUBLIC HEALTH AND THE NATIONS HEALTH, 1959, 49 (07): : 963 - 963
  • [7] INTERNATIONAL STANDARDS - WHO SHOULD GET INVOLVED
    不详
    AMERICAN CERAMIC SOCIETY BULLETIN, 1990, 69 (05): : 783 - 784
  • [8] Role for standards in assays of botulinum toxins: international collaborative study of three preparations of botulinum type A toxin
    Sesardic, D
    Leung, T
    Das, RG
    BIOLOGICALS, 2003, 31 (04) : 265 - 276
  • [9] Development of an Innovative in Vitro Potency Assay for Anti-Botulinum Antitoxins
    Rosen, Osnat
    Ozeri, Eyal
    Barnea, Ada
    Ben David, Alon
    Zichel, Ran
    TOXINS, 2016, 8 (10):
  • [10] Biological substances: WHO International Standards and Reference Panels
    WHO EXPERT COMMITTEE ON BIOLOGICAL STANDARDIZATION: SIXTY-FOURTH REPORT, 2014, 987 : 265 - 266